SCHEMBL124387

SCHEMBL124387

N[C@@H](CCC(=O)O)C(=O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 6/20 0.56
SLC15A1 P46059 1/20 0.50
HTT P42858 1/20 0.49
ALDH1A1 P00352 3/20 0.49
IDO1 P14902 1/20 0.48
CPA3 P15088 1/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KMT2A Q03164 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
SLC1A3 P43003 1/20 0.47
SLC1A1 P43005 1/20 0.47
FOLH1 Q04609 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28192478 1.00 LTA4H (0.56) LTA4HSLC15A1HTTALDH1A1IDO1
SCHEMBL21232385 1.00 LTA4H (0.56) LTA4HSLC15A1HTTALDH1A1IDO1
SCHEMBL561573 1.00 LTA4H (0.56) LTA4HSLC15A1HTTALDH1A1IDO1
Hydrochloric Acid SCHEMBL29398707 0.98 LTA4H (0.54) LTA4HSLC15A1HTTALDH1A1IDO1
Hydrochloric Acid SCHEMBL15266392 0.98 LTA4H (0.54) LTA4HSLC15A1HTTALDH1A1IDO1
SCHEMBL29720984 0.98 LTA4H (0.54) LTA4HSLC15A1HTTALDH1A1IDO1
Hydrochloric Acid SCHEMBL7263807 0.98 LTA4H (0.54) LTA4HSLC15A1HTTALDH1A1IDO1
Ethylene Glycol SCHEMBL27895455 0.95 LTA4H (0.52) LTA4HSLC15A1HTTALDH1A1IDO1
SCHEMBL27324538 0.93 LTA4H (0.59) LTA4HSLC15A1HTTALDH1A1SLC1A3
Alanine SCHEMBL4410295 0.93 LTA4H (0.50) LTA4HSLC15A1ALDH1A1CPA3SLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4695257-A1 PROCESS FOR THE PREPARATION OF REMIMAZOLAM AND SALTS THEREOF Harman Finochem Limited (IN) 2026-02-18 EP claimed
US-20260027218-A1 STAR-SHAPED GRAFT COPOLYMERS POLYPEPTIDE THERAPEUTIC SOLUTIONS S L (ES) 2026-01-29 US claimed
EP-4674441-A1 RARE EARTH NANO FLUORESCENCE-NUCLEAR MEDICINE TUMOR TOMOGRAPHY-THERAPY INTEGRATED PREPARATION, PREPARING METHOD THEREFOR, AND USE METHOD AND USE THEREOF Zhongke Rare Earth Nanotechnology (Hebei) Co., Ltd (CN) 2026-01-07 EP claimed
EP-4622988-A1 DITHIOL CHELATORS FOR METAL CONJUGATION TO ANTIBODIES Standard Biotools Canada Inc. (CA) 2025-10-01 EP claimed
CN-119823018-A Preparation method of semaglutin side chain deprotection active ester 恒敬合创生物医药(浙江)有限公司 2025-04-15 CN claimed
EP-4532586-A1 STAR-SHAPED GRAFT COPOLYMERS Polypeptide Therapeutic Solutions, S.L. (ES) 2025-04-09 EP claimed
CN-119605880-A Processing technology of floating beam green tea 浮梁县天祥茶号有限公司 2025-03-14 CN claimed
CN-119585343-A Star graft copolymers 多肽治疗解决公司 2025-03-07 CN claimed
CN-115612049-B Compound imitating spider silk structure, preparation method and application thereof 上海凯赛生物技术股份有限公司 2025-02-11 CN claimed
CN-118979320-A Antibacterial and antistatic cellulose blended yarn and preparation method thereof 德州华源生态科技有限公司 2024-11-19 CN claimed
US-5602161-A ELASTASE INHIBITORS; PREVENTING AND TREATING EMPHYSEMA, ENDOTOXIN-INDUCED LUNG DISORDERS WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1997-02-11 US claimed
EP-0676396-A1 Tetrazolylphenyl pivalate derivatives and medicinal composition containing the same as effective component Wakamoto Pharmaceutical Co., Ltd. (JP) 1995-10-11 EP claimed
EP-0565646-A4 1994-08-03 EP claimed
EP-0565646-A1 NUCLEOSIDES AND OLIGONUCLEOSIDES WITH A PHOSPHATE-FREE INTERNUCLEOSIDE BACKBONE AND PROCESS FOR PREPARING THE SAME BAYLOR COLLEGE OF MEDICINE (US) 1993-10-20 EP claimed
US-5250517-A Hypotensive and cardiotonic agents; cardiac insufficiency HOFFMANN-LA ROCHE INC. (US) 1993-10-05 US claimed
EP-0362031-B1 COMPOUNDS ACTIVE AGAINST MALARIA OF THE TISSUES, AND PROCESS FOR THEIR PREPARATION LA REGION WALLONNE (BE) 1993-07-07 EP claimed
WO-1992018518-A1 NUCLEOSIDES AND OLIGONUCLEOSIDES WITH A PHOSPHATE-FREE INTERNUCLEOSIDE BACKBONE AND PROCESS FOR PREPARING THE SAME BAYLOR COLLEGE OF MEDICINE (US) 1992-10-29 WO claimed
EP-0362031-A1 Compounds active against malaria of the tissues, and process for their preparation LA REGION WALLONNE (BE) 1990-04-04 EP claimed
EP-0213996-B1 RAMIFIED POLYMERS BASED ON LIPOPEPTIDES FORMING THERMOTROPIC AND LYOTROPIC LIQUID CRYSTALS, THEIR USE AND CORRESPONDING MONOMERS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1989-09-06 EP claimed
US-3936469-A Process for preparing N-carboxylic anhydrides of amino acids KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JA) 1976-02-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260027218-A1 STAR-SHAPED GRAFT COPOLYMERS RHOA, PCNA, HBZ LTA4H 4148/4885SLC15A1 2709/4885HTT 1055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.